FundaMental Pharma

Heidelberg, Germany Founded: 2016 • Age: 10 yrs
Provider of drug development research services for peptides gene therapy, and neurological diseases
Request Access

About FundaMental Pharma

FundaMental Pharma is a company based in Heidelberg (Germany) founded in 2016 by Daniela Mauceri, Thomas Schulze, and Hilmar Bading.. FundaMental Pharma has raised $10.32 million across 2 funding rounds from investors including High-Tech Gründerfonds, coparion and BioGeneration Ventures. FundaMental Pharma offers products and services including NMDAR/TRPM4 Interface Inhibitors. FundaMental Pharma operates in a competitive market with competitors including Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.

  • Headquarter Heidelberg, Germany
  • Founders Daniela Mauceri, Thomas Schulze, Hilmar Bading
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Fundamental Pharma Gmbh
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $10.32 M (USD)

    in 2 rounds

  • Latest Funding Round
    $10.32 M (USD), Seed

    Nov 21, 2022

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of FundaMental Pharma

FundaMental Pharma offers a comprehensive portfolio of products and services, including NMDAR/TRPM4 Interface Inhibitors. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Inhibitors that selectively target neurotoxicity in neurodegeneration while preserving brain functions.

People of FundaMental Pharma
Headcount 1-10
Employee Profiles 3
Employee Profiles
People
Dirk Beher
CEO
People
Alexander Straub
Head Of
People
Thomas Fink
Head Of Finance

Unlock access to complete

Funding Insights of FundaMental Pharma

FundaMental Pharma has successfully raised a total of $10.32M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $10.32 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Seed — $10.3M
  • First Round
  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2022 Amount Seed - FundaMental Pharma Valuation BioGeneration Ventures , Thuja Capital
Jun, 2021 Amount Seed - FundaMental Pharma Valuation HTGF
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in FundaMental Pharma

FundaMental Pharma has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include High-Tech Gründerfonds, coparion and BioGeneration Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Early-stage investments are made in high-tech startups by HTGF.
Founded Year Domain Location
Venture capital funding for young German technology companies.
Founded Year Domain Location
Life science focused VC firm investing in startups in Europe
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by FundaMental Pharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - FundaMental Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Fundamental Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of FundaMental Pharma

FundaMental Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Laboratory testing and contract research services are provided globally.
domain founded_year HQ Location
Provider of CRO and CDMO services
domain founded_year HQ Location
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
domain founded_year HQ Location
Branded pharmaceutical products are developed, marketed, and distributed globally.
domain founded_year HQ Location
Branded and generic prescription drugs are developed, manufactured, and marketed.
domain founded_year HQ Location
CRO focused on clinical development for phases II & III clinical trials and regulatory affair services
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about FundaMental Pharma

When was FundaMental Pharma founded?

FundaMental Pharma was founded in 2016 and raised its 1st funding round 5 years after it was founded.

Where is FundaMental Pharma located?

FundaMental Pharma is headquartered in Heidelberg, Germany. It is registered at Heidelberg, Baden-wurttemberg, Germany.

Is FundaMental Pharma a funded company?

FundaMental Pharma is a funded company, having raised a total of $10.32M across 2 funding rounds to date.

What does FundaMental Pharma do?

FundaMental Pharma was founded in 2016 in Heidelberg, Germany, as a provider of drug development and research services. Focus is placed on peptides and gene therapy, particularly for neurological diseases. Operations involve collaborative research efforts in the pharmaceutical sector, with services extending to preclinical studies and therapeutic innovation. The company is co-founded by Daniela Mauceri, Thomas Schulze, and Hilmar Bading, supporting advancements in targeted treatments.

Who are the top competitors of FundaMental Pharma?

FundaMental Pharma's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.

What products or services does FundaMental Pharma offer?

FundaMental Pharma offers NMDAR/TRPM4 Interface Inhibitors.

Who are FundaMental Pharma's investors?

FundaMental Pharma has 4 investors. Key investors include High-Tech Gründerfonds, coparion, BioGeneration Ventures, and Thuja Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available